{"filings":[{"id":762756,"accession_number":"0001213900-26-063235","cik":1839140,"company_name":"Revium Rx.","ticker":"RVRC","form_type":"8-K","filed_at":"2026-06-01T13:58:55+00:00","items":["5.02"],"status":"ready","headline":"Revium Rx CFO Arie Gordashnikov resigns; Igor Bluvstein appointed effective May 27, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Arie Gordashnikov resigned as CFO effective May 27, 2026, with no disagreement with the company.","Igor Bluvstein appointed CFO same date; previously CFO at Argent BioPharma and G Medical Innovations.","Bluvstein receives monthly retainer of NIS17,000 plus VAT.","Bluvstein has over 17 years of financial leadership experience and is a CPA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":101417600.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96072,"accession_number":"0001213900-26-045633","cik":1839140,"company_name":"Revium Rx.","ticker":"RVRC","form_type":"8-K","filed_at":"2026-04-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Revium Rx appoints Amir Avraham permanent CEO, Shlomi Schwartzblat as Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Amir Avraham as permanent CEO (was interim since May 2025), effective Feb 1, 2026.","Monthly salary of NIS 55,000; eligible for annual discretionary bonus and one-time $50,000 bonus if $5M equity raised within 18 months.","Option grant of 1,300,000 shares vesting from Feb 1, 2026; additional 300,000 upon $3M investments, and 300,000 upon M&A completion.","Appointed Shlomi Schwartzblat as Director and Chairman of the Board, effective immediately, term through 2026 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":101417600.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}